GlassScriptPhysician profile
Janet Conrad
NPI 1790310035
$2,140.74
in general payments reported to CMS, 2019-2025
20 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $195 · 2022: $469 · 2023: $551 · 2024: $606 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,476.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $750.48 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $410.45 | 2021-2025 | |
| Lilly USA, LLC | $247.32 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Xeris Pharmaceuticals, INC. | $120.50 | 2024-2025 | Gvoke Hypopen |
| Exact Sciences Corporation | $87.48 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $73.59 | 2022-2023 | |
| Otsuka America Pharmaceutical, INC. | $56.12 | 2022-2024 | Rexulti |
| Amarin Pharma, INC. | $46.86 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $46.35 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $41.35 | 2022-2025 | Seglentis, Zoryve |
| Amgen INC. | $38.41 | 2024 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $37.29 | 2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Seqirus USA INC | $31.28 | 2024-2025 | Fluad, Flucelvax |
| Astellas Pharma US INC | $28.64 | 2024 | Veozah |
| Daiichi Sankyo INC. | $28.57 | 2025 | Injectafer |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $21.66 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.71 | 2022 | |
| Janssen Pharmaceuticals, INC | $19.83 | 2022 | |
| Dexcom, INC. | $17.63 | 2021 | |
| Phathom Pharmaceuticals, INC. | $16.22 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Conrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.